John Paulson (Trades, Portfolio) increased his position in Actavis PLC (NYSE:ACT) through Paulson & Co by 262% to $1.68 billion in the company's latest filing, with 5.6 million shares. Actavis is the fund's second largest holding in its $19.64 billion portfolio behind Shire PLC (NASDAQ:SHPG) and Time Warner Cable Inc (NYSE:TWC), representing 10.1% and 6.6% of Paulson's portfolio, respectively.
Actavis PLC, formerly known as Actavis Limited was incorporated in Ireland, in 2013. It is an integrated specialty pharmaceutical company engaged in development, manufacturing, marketing, sale and distribution of generic, branded generic, brand name, biosimilar and over-the-counter pharmaceutical products. Continue Reading »